Krystal Biotech, Inc. (KRYS)

267.39 -7.20 (-2.62%) USD  |  NASDAQ  |  Feb 24, 11:44
More

Krystal Biotech Cash from Discontinued Operations Adjustment (Quarterly)

Cash from Discontinued Operations Adjustment (Quarterly) Chart

View Cash from Discontinued Operations Adjustment (Quarterly) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Discontinued Operations Adjustment (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
DexCom, Inc. --
Alkermes Plc --
Regeneron Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --